Asosiy kontentga oʻtish
Sharh maqola

Transport, stability, and biological activity of resveratrol

Dominique DelmasInserm U866, Dijon, FranceVirginie AiresInserm U866, Dijon, FranceEmeric LimagneInserm U866, Dijon, FrancePatrick DutartreCOHIRO, Faculté de Médecine, Dijon, FranceFrédéric MazuéUniversité de Bourgogne, Faculté des Sciences Gabriel, Centre de Recherche-Biochimie Métabolique et Nutritionnelle, Dijon, FranceFrançois GhiringhelliUniversité de Bourgogne, Faculté de Médecine, Centre de Recherche-Immunothérapie et Chimiothérapie des Cancers, Dijon, FranceNorbert LatruffeInserm U866, Dijon, France
2011en
ABI

Annotatsiya

Numerous studies have reported interesting properties of trans-resveratrol, a phytoalexin, as a preventive agent of several important pathologies: vascular diseases, cancers, viral infections, and neurodegenerative processes. These beneficial effects of resveratrol have been supported by observations at the cellular and molecular levels in both cellular and in vivo models, but the cellular fate of resveratrol remains unclear. We suggest here that resveratrol uptake, metabolism, and stability of the parent molecule could influence the biological effects of resveratrol. It appears that resveratrol stability involves redox reactions and biotransformation that influence its antioxidant properties. Resveratrol's pharmacokinetics and metabolism represent other important issues, notably, the putative effects of its metabolites on pathology models. For example, some metabolites, mainly sulfate-conjugated resveratrol, show biological effects in cellular models. The modifications of resveratrol stability, chemical structure, and metabolism could change its cellular and molecular targets and could be crucial for improving or decreasing its chemopreventive properties.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba